Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States, Israel, and internationally. It serves consumers through its platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty, wellness, and technology products. The company provides a portfolio of products, including face and complexion, eye, brow and lip products, makeup tools, bodycare, medical grade prescription and OTC products, skincare, color cosmetics, haircare, and supplements under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which deploys AI-based molecule discovery technology to identify and launch novel ingredients that delivers performance and outcomes for consumers in beauty and wellness. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Jaffa, Israel.…
Oddity Tech (ODD) Stock Sees Fair Value Lift As Analysts Raise Targets
Oddity Tech (NASDAQ: ODD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Household & Personal Products industry, part of the Consumer Defensive sector, and reports about 658 employees.
The shares were at 13.62 USD on 20 November 2026, down 65.9% over 52 weeks. Its 52-week range is 9.250 USD to 46.45 USD: the price is 70.7% below the high and 47.2% above the low.
At a market capitalisation of 628.22M USD, it trades at 90.8 times trailing earnings and 15.8 times forward earnings. The median trailing P/E of its 20 largest Household & Personal Products peers is 18.8, a premium of 384% for ODD.
Oddity Tech reports return on equity of 27.9%, an operating margin of -2.2% and revenue down 2.0% year over year.
Its debt exceeds its cash by 360.61M USD, a debt-to-equity ratio of 1.53. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Hold; their mean price target of 16.94 USD is 24.4% above the current price. The next earnings report is expected on 24 February 2027.